South32’s $4.7bn Hermosa project clears key US approval as critical minerals push accelerates
IXICO lifts revenue forecast on contract wins and wider client base - UPDATE
IXICO lifts revenue forecast on contract wins and wider client base
SpaceX stock surges in hotly anticipated market debut
IXICO expands scientific network in Alzheimer's and Parkinson's disease
Percheron Therapeutics secures proposed WHO drug name for HMBD-002 cancer therapy
Walmart price target lowered by UBS as Q1 results miss elevated expectations
Bram Goorden discusses IXICO growth plans - ICYMI
Bram Goorden discusses IXICO growth plans - ICYMI
IXICO plc (PHYOF) Q2 2026 Earnings Call Transcript
Zscaler set to benefit from federal tailwinds boosting fourth quarter outlook: analysts
IXICO contract wins provide near-total revenue visibility for current year
IXICO wins £1.3 million in Alzheimer's and Huntington's contracts
UK utility investors face prolonged uncertainty after worst sell-off since privatisation era
Cavendish sees IXICO forecasts as conservative after order book hits five-year high
Cavendish sees IXICO forecasts as conservative after order book hits five-year high
IXICO targets 15% revenue growth as order book swells and strategy takes shape
Rigetti Computing tops Q1 earnings estimates as loss narrows
IXICO launches latest version of AI neuroimaging platform
IXICO launches latest version of AI neuroimaging platform
IXICO boss says Medidata collab is poster child of partnership plans - ICYMI
IXICO boss says Medidata collab is poster child of partnership plans - ICYMI
Lindian secures US$11.6M facility with Malawian bank to support Kangankunde ramp-up
Dow Jones, Nasdaq close lower as US-Iran peace talks stall, UnitedHealth surges on earnings
Eli Lilly’s Kelonia Therapeutics acquisition seen as strategic bet on next-generation CAR-T: analysts
Rivian Automotive platform push unlikely to gain near-term traction, says UBS
Xcel Energy seen as undervalued as UBS lifts price target
Procter & Gamble cost pressures in focus for Q3 report
McDonald’s Q1 profit seen slightly below estimates as Jefferies trims sales outlook
Halliburton beats estimates as shares rise on early signs of North America recovery
Cavendish sees significant upside in IXICO as surging order book and £10m raise point to growth inflexion
Uranium American Resources completes JAG Minerals acquisition
Cavendish sees significant upside in IXICO as surging order book and £10m raise point to growth inflexion
IXICO reports 23% revenue rise as order book surges 38% in first half
Biogen to acquire Apellis Pharmaceuticals for $5.6B, adding C3 therapies to portfolio
IXICO could target tenfold market expansion with £10m raise and AI platform pivot - broker
IXICO raising up to £10.5m to develop AI neuroscience platform and pursue FDA approval
IXICO boss on 'tech bio' deal that creates solution for clinical trials - ICYMI
IXICO boss on 'tech bio' deal that creates solution for clinical trials - ICYMI
Reddit introduces new age and human verification measures
Dow dips, Nasdaq falls as oil surges, Trump says Iran 'better get serious'
IXICO strikes neuroimaging deal with Medidata to expand clinical trial platform
IXICO strikes neuroimaging deal with Medidata to expand clinical trial platform
Celsius shares jump on strong fourth quarter results
IXICO says its AI brain imaging tool matches or beats human experts
IXICO boosts pipeline with Huntington's Disease trial contract
IXICO eyes accelerated business development activity as it hires new CCO
Nasdaq leads Wall Street higher as 2026 trading kicks off
2026 a pivotal year for consumer internet and e-commerce, says Wedbush
Tower Semiconductor shares held steady by strong silicon photonics demand, Wedbush says